nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—Injection site burning—Carmustine—malignant glioma	0.147	0.178	CcSEcCtD
Gadoxetate—Clotting—Temozolomide—malignant glioma	0.0374	0.0453	CcSEcCtD
Gadoxetate—Parosmia—Temozolomide—malignant glioma	0.0206	0.0249	CcSEcCtD
Gadoxetate—Necrosis—Carmustine—malignant glioma	0.0176	0.0213	CcSEcCtD
Gadoxetate—Abscess—Carmustine—malignant glioma	0.0175	0.0212	CcSEcCtD
Gadoxetate—Coagulopathy—Temozolomide—malignant glioma	0.0172	0.0208	CcSEcCtD
Gadoxetate—Injection site pain—Carmustine—malignant glioma	0.0169	0.0205	CcSEcCtD
Gadoxetate—Extravasation—Carmustine—malignant glioma	0.0159	0.0192	CcSEcCtD
Gadoxetate—Injection site reaction—Carmustine—malignant glioma	0.0137	0.0166	CcSEcCtD
Gadoxetate—Sepsis—Carmustine—malignant glioma	0.012	0.0145	CcSEcCtD
Gadoxetate—Phlebitis—Carmustine—malignant glioma	0.0117	0.0141	CcSEcCtD
Gadoxetate—Swelling—Carmustine—malignant glioma	0.0114	0.0138	CcSEcCtD
Gadoxetate—Face oedema—Carmustine—malignant glioma	0.00969	0.0117	CcSEcCtD
Gadoxetate—Face oedema—Temozolomide—malignant glioma	0.00937	0.0113	CcSEcCtD
Gadoxetate—Hypokalaemia—Carmustine—malignant glioma	0.00914	0.0111	CcSEcCtD
Gadoxetate—Dehydration—Temozolomide—malignant glioma	0.00902	0.0109	CcSEcCtD
Gadoxetate—Hypokalaemia—Temozolomide—malignant glioma	0.00883	0.0107	CcSEcCtD
Gadoxetate—Dysphagia—Carmustine—malignant glioma	0.00868	0.0105	CcSEcCtD
Gadoxetate—Abdominal distension—Temozolomide—malignant glioma	0.00844	0.0102	CcSEcCtD
Gadoxetate—Dysphagia—Temozolomide—malignant glioma	0.00839	0.0101	CcSEcCtD
Gadoxetate—Sweating increased—Temozolomide—malignant glioma	0.00817	0.00988	CcSEcCtD
Gadoxetate—SLCO1B3—Transport of vitamins, nucleosides, and related molecules—APOD—malignant glioma	0.00812	0.0468	CbGpPWpGaD
Gadoxetate—Bronchitis—Temozolomide—malignant glioma	0.00806	0.00976	CcSEcCtD
Gadoxetate—Renal failure—Carmustine—malignant glioma	0.0076	0.0092	CcSEcCtD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNND2—malignant glioma	0.00725	0.0418	CbGpPWpGaD
Gadoxetate—Hypoaesthesia—Carmustine—malignant glioma	0.00691	0.00836	CcSEcCtD
Gadoxetate—Connective tissue disorder—Carmustine—malignant glioma	0.00682	0.00826	CcSEcCtD
Gadoxetate—Hypoaesthesia—Temozolomide—malignant glioma	0.00668	0.00808	CcSEcCtD
Gadoxetate—Connective tissue disorder—Temozolomide—malignant glioma	0.0066	0.00798	CcSEcCtD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00655	0.0377	CbGpPWpGaD
Gadoxetate—Flushing—Carmustine—malignant glioma	0.00645	0.0078	CcSEcCtD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00624	0.0359	CbGpPWpGaD
Gadoxetate—Flushing—Temozolomide—malignant glioma	0.00623	0.00754	CcSEcCtD
Gadoxetate—Cardiac disorder—Temozolomide—malignant glioma	0.00623	0.00754	CcSEcCtD
Gadoxetate—Arrhythmia—Carmustine—malignant glioma	0.0062	0.00751	CcSEcCtD
Gadoxetate—ABCC2—Irinotecan Pathway—BCHE—malignant glioma	0.00615	0.0354	CbGpPWpGaD
Gadoxetate—Angiopathy—Temozolomide—malignant glioma	0.00609	0.00737	CcSEcCtD
Gadoxetate—Immune system disorder—Temozolomide—malignant glioma	0.00606	0.00734	CcSEcCtD
Gadoxetate—Mediastinal disorder—Temozolomide—malignant glioma	0.00605	0.00732	CcSEcCtD
Gadoxetate—Chills—Temozolomide—malignant glioma	0.00602	0.00729	CcSEcCtD
Gadoxetate—Back pain—Carmustine—malignant glioma	0.00585	0.00708	CcSEcCtD
Gadoxetate—SLCO1B1—Irinotecan Pathway—BCHE—malignant glioma	0.00577	0.0332	CbGpPWpGaD
Gadoxetate—Dysgeusia—Temozolomide—malignant glioma	0.00572	0.00692	CcSEcCtD
Gadoxetate—Vision blurred—Carmustine—malignant glioma	0.0057	0.0069	CcSEcCtD
Gadoxetate—Tremor—Carmustine—malignant glioma	0.00566	0.00685	CcSEcCtD
Gadoxetate—Back pain—Temozolomide—malignant glioma	0.00565	0.00684	CcSEcCtD
Gadoxetate—Agitation—Carmustine—malignant glioma	0.00556	0.00672	CcSEcCtD
Gadoxetate—Vision blurred—Temozolomide—malignant glioma	0.00551	0.00666	CcSEcCtD
Gadoxetate—Tremor—Temozolomide—malignant glioma	0.00547	0.00662	CcSEcCtD
Gadoxetate—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—APOD—malignant glioma	0.00546	0.0314	CbGpPWpGaD
Gadoxetate—Ill-defined disorder—Temozolomide—malignant glioma	0.00542	0.00656	CcSEcCtD
Gadoxetate—Agitation—Temozolomide—malignant glioma	0.00537	0.0065	CcSEcCtD
Gadoxetate—Malaise—Temozolomide—malignant glioma	0.00527	0.00638	CcSEcCtD
Gadoxetate—Vertigo—Temozolomide—malignant glioma	0.00525	0.00635	CcSEcCtD
Gadoxetate—Convulsion—Carmustine—malignant glioma	0.00524	0.00634	CcSEcCtD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.00519	0.0299	CbGpPWpGaD
Gadoxetate—Palpitations—Temozolomide—malignant glioma	0.00516	0.00625	CcSEcCtD
Gadoxetate—Chest pain—Carmustine—malignant glioma	0.00515	0.00623	CcSEcCtD
Gadoxetate—Anxiety—Carmustine—malignant glioma	0.00513	0.00621	CcSEcCtD
Gadoxetate—Cough—Temozolomide—malignant glioma	0.0051	0.00617	CcSEcCtD
Gadoxetate—Convulsion—Temozolomide—malignant glioma	0.00506	0.00613	CcSEcCtD
Gadoxetate—Anxiety—Temozolomide—malignant glioma	0.00496	0.006	CcSEcCtD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.00495	0.0285	CbGpPWpGaD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00494	0.00598	CcSEcCtD
Gadoxetate—Oedema—Carmustine—malignant glioma	0.00493	0.00597	CcSEcCtD
Gadoxetate—Discomfort—Temozolomide—malignant glioma	0.00491	0.00595	CcSEcCtD
Gadoxetate—Infection—Carmustine—malignant glioma	0.0049	0.00593	CcSEcCtD
Gadoxetate—Dry mouth—Temozolomide—malignant glioma	0.00486	0.00589	CcSEcCtD
Gadoxetate—Tachycardia—Carmustine—malignant glioma	0.00482	0.00583	CcSEcCtD
Gadoxetate—Anaphylactic shock—Temozolomide—malignant glioma	0.00477	0.00577	CcSEcCtD
Gadoxetate—Oedema—Temozolomide—malignant glioma	0.00477	0.00577	CcSEcCtD
Gadoxetate—Infection—Temozolomide—malignant glioma	0.00474	0.00573	CcSEcCtD
Gadoxetate—Anorexia—Carmustine—malignant glioma	0.0047	0.00569	CcSEcCtD
Gadoxetate—Nervous system disorder—Temozolomide—malignant glioma	0.00468	0.00566	CcSEcCtD
Gadoxetate—Skin disorder—Temozolomide—malignant glioma	0.00463	0.0056	CcSEcCtD
Gadoxetate—Hypotension—Carmustine—malignant glioma	0.00461	0.00558	CcSEcCtD
Gadoxetate—Hyperhidrosis—Temozolomide—malignant glioma	0.00461	0.00558	CcSEcCtD
Gadoxetate—Anorexia—Temozolomide—malignant glioma	0.00455	0.0055	CcSEcCtD
Gadoxetate—Paraesthesia—Carmustine—malignant glioma	0.00443	0.00536	CcSEcCtD
Gadoxetate—Dyspnoea—Carmustine—malignant glioma	0.0044	0.00532	CcSEcCtD
Gadoxetate—Decreased appetite—Carmustine—malignant glioma	0.00429	0.00519	CcSEcCtD
Gadoxetate—Paraesthesia—Temozolomide—malignant glioma	0.00428	0.00518	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00426	0.00516	CcSEcCtD
Gadoxetate—Dyspnoea—Temozolomide—malignant glioma	0.00425	0.00514	CcSEcCtD
Gadoxetate—Constipation—Carmustine—malignant glioma	0.00422	0.00511	CcSEcCtD
Gadoxetate—Decreased appetite—Temozolomide—malignant glioma	0.00415	0.00502	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00412	0.00498	CcSEcCtD
Gadoxetate—Fatigue—Temozolomide—malignant glioma	0.00411	0.00497	CcSEcCtD
Gadoxetate—Constipation—Temozolomide—malignant glioma	0.00408	0.00493	CcSEcCtD
Gadoxetate—Feeling abnormal—Carmustine—malignant glioma	0.00407	0.00492	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Carmustine—malignant glioma	0.00403	0.00488	CcSEcCtD
Gadoxetate—Feeling abnormal—Temozolomide—malignant glioma	0.00393	0.00476	CcSEcCtD
Gadoxetate—Abdominal pain—Carmustine—malignant glioma	0.0039	0.00472	CcSEcCtD
Gadoxetate—Body temperature increased—Carmustine—malignant glioma	0.0039	0.00472	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Temozolomide—malignant glioma	0.0039	0.00472	CcSEcCtD
Gadoxetate—Urticaria—Temozolomide—malignant glioma	0.00379	0.00458	CcSEcCtD
Gadoxetate—Abdominal pain—Temozolomide—malignant glioma	0.00377	0.00456	CcSEcCtD
Gadoxetate—Body temperature increased—Temozolomide—malignant glioma	0.00377	0.00456	CcSEcCtD
Gadoxetate—Hypersensitivity—Carmustine—malignant glioma	0.00364	0.0044	CcSEcCtD
Gadoxetate—Asthenia—Carmustine—malignant glioma	0.00354	0.00428	CcSEcCtD
Gadoxetate—Hypersensitivity—Temozolomide—malignant glioma	0.00351	0.00425	CcSEcCtD
Gadoxetate—Asthenia—Temozolomide—malignant glioma	0.00342	0.00414	CcSEcCtD
Gadoxetate—Diarrhoea—Carmustine—malignant glioma	0.00338	0.00409	CcSEcCtD
Gadoxetate—Pruritus—Temozolomide—malignant glioma	0.00337	0.00408	CcSEcCtD
Gadoxetate—ABCC2—Irinotecan Pathway—APC—malignant glioma	0.00334	0.0192	CbGpPWpGaD
Gadoxetate—Dizziness—Carmustine—malignant glioma	0.00326	0.00395	CcSEcCtD
Gadoxetate—Diarrhoea—Temozolomide—malignant glioma	0.00326	0.00395	CcSEcCtD
Gadoxetate—Dizziness—Temozolomide—malignant glioma	0.00315	0.00382	CcSEcCtD
Gadoxetate—Vomiting—Carmustine—malignant glioma	0.00314	0.0038	CcSEcCtD
Gadoxetate—SLCO1B1—Irinotecan Pathway—APC—malignant glioma	0.00313	0.0181	CbGpPWpGaD
Gadoxetate—Rash—Carmustine—malignant glioma	0.00311	0.00376	CcSEcCtD
Gadoxetate—Dermatitis—Carmustine—malignant glioma	0.00311	0.00376	CcSEcCtD
Gadoxetate—Headache—Carmustine—malignant glioma	0.00309	0.00374	CcSEcCtD
Gadoxetate—Vomiting—Temozolomide—malignant glioma	0.00303	0.00367	CcSEcCtD
Gadoxetate—Rash—Temozolomide—malignant glioma	0.00301	0.00364	CcSEcCtD
Gadoxetate—Dermatitis—Temozolomide—malignant glioma	0.003	0.00363	CcSEcCtD
Gadoxetate—Headache—Temozolomide—malignant glioma	0.00299	0.00361	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—FTH1—malignant glioma	0.00294	0.0169	CbGpPWpGaD
Gadoxetate—Nausea—Carmustine—malignant glioma	0.00293	0.00355	CcSEcCtD
Gadoxetate—Nausea—Temozolomide—malignant glioma	0.00283	0.00343	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—FTH1—malignant glioma	0.00276	0.0159	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—PIM1—malignant glioma	0.00239	0.0138	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—FTH1—malignant glioma	0.00233	0.0134	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.002	0.0115	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00174	0.01	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—KNG1—malignant glioma	0.00159	0.00914	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.00158	0.00912	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—SOX2—malignant glioma	0.00154	0.00888	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—malignant glioma	0.00151	0.00871	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—SOD1—malignant glioma	0.00147	0.00849	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—DOCK6—malignant glioma	0.00147	0.00849	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—SOD1—malignant glioma	0.0014	0.00808	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC5A5—malignant glioma	0.00117	0.00676	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00117	0.00675	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00114	0.00656	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—PDGFB—malignant glioma	0.00114	0.00655	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—SLC6A3—malignant glioma	0.00112	0.00643	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC5A5—malignant glioma	0.0011	0.00635	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—PDGFB—malignant glioma	0.00108	0.00624	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—SLC6A3—malignant glioma	0.00105	0.00605	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00104	0.006	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00103	0.00592	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—FN1—malignant glioma	0.00103	0.00591	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—FN1—malignant glioma	0.000977	0.00563	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—EGF—malignant glioma	0.00097	0.00559	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000967	0.00557	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—malignant glioma	0.000958	0.00552	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—GSTP1—malignant glioma	0.000945	0.00544	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00094	0.00542	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	0.000931	0.00536	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—RTEL1—malignant glioma	0.000929	0.00535	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—EGF—malignant glioma	0.000924	0.00532	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000911	0.00525	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—malignant glioma	0.000901	0.00519	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ATP1B2—malignant glioma	0.000893	0.00514	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—GSTP1—malignant glioma	0.000889	0.00512	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—APOD—malignant glioma	0.000886	0.0051	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	0.000886	0.0051	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000884	0.00509	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—RTEL1—malignant glioma	0.000838	0.00483	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000822	0.00473	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00082	0.00472	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000815	0.00469	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—APOD—malignant glioma	0.0008	0.0046	CbGpPWpGaD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00078	0.00449	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000773	0.00445	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.000766	0.00441	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—APOD—malignant glioma	0.000752	0.00433	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—GSTP1—malignant glioma	0.00075	0.00432	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—PDGFB—malignant glioma	0.000747	0.0043	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.000746	0.00429	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—KNG1—malignant glioma	0.000704	0.00405	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—PDGFB—malignant glioma	0.000703	0.00405	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.0007	0.00403	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000664	0.00382	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—ANGPT2—malignant glioma	0.000658	0.00379	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000654	0.00376	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000652	0.00375	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000643	0.0037	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	0.000634	0.00365	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—RTEL1—malignant glioma	0.000624	0.0036	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000612	0.00352	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.0006	0.00346	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000599	0.00345	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000595	0.00343	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—PDGFB—malignant glioma	0.000593	0.00341	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—malignant glioma	0.000587	0.00338	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.00058	0.00334	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HIST1H3B—malignant glioma	0.00057	0.00328	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—MYB—malignant glioma	0.000565	0.00325	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—malignant glioma	0.000559	0.00322	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000551	0.00317	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—COX8A—malignant glioma	0.000534	0.00307	CbGpPWpGaD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000524	0.00302	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.000504	0.0029	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—COX8A—malignant glioma	0.000482	0.00277	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000477	0.00275	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000455	0.00262	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—F2—malignant glioma	0.000455	0.00262	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ASMT—malignant glioma	0.000454	0.00261	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000454	0.00261	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	0.000446	0.00257	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000444	0.00255	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—H3F3A—malignant glioma	0.00044	0.00254	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000435	0.00251	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	0.000432	0.00249	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000431	0.00248	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.00043	0.00248	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCAN—malignant glioma	0.000427	0.00246	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000417	0.0024	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ASMT—malignant glioma	0.000409	0.00236	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000409	0.00236	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.0004	0.0023	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000398	0.00229	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000397	0.00228	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCAN—malignant glioma	0.000385	0.00222	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000385	0.00222	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	0.000383	0.0022	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000376	0.00216	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KNG1—malignant glioma	0.000363	0.00209	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—COX8A—malignant glioma	0.000359	0.00207	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000358	0.00206	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNA2—malignant glioma	0.000355	0.00205	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000353	0.00204	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—malignant glioma	0.000349	0.00201	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—IDH2—malignant glioma	0.000344	0.00198	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—RAF1—malignant glioma	0.000342	0.00197	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SOD1—malignant glioma	0.000337	0.00194	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000336	0.00194	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	0.000334	0.00192	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000325	0.00187	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000324	0.00187	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2B6—malignant glioma	0.000323	0.00186	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	0.000321	0.00185	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—IDH2—malignant glioma	0.00031	0.00179	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PTK2—malignant glioma	0.000309	0.00178	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—IL2—malignant glioma	0.000306	0.00176	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ASMT—malignant glioma	0.000305	0.00176	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000305	0.00176	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000298	0.00172	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	0.000298	0.00172	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—IDH1—malignant glioma	0.000296	0.0017	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000293	0.00169	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2B6—malignant glioma	0.000292	0.00168	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCAN—malignant glioma	0.000287	0.00165	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SPHK1—malignant glioma	0.000286	0.00165	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000284	0.00163	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CYP2C18—malignant glioma	0.00028	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00028	0.00161	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—IDH1—malignant glioma	0.000267	0.00154	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.000266	0.00153	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000264	0.00152	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	0.00026	0.0015	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PDGFB—malignant glioma	0.00026	0.0015	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SPHK1—malignant glioma	0.000258	0.00149	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CYP2C18—malignant glioma	0.000253	0.00146	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—CAV1—malignant glioma	0.000246	0.00142	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000241	0.00139	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000239	0.00137	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—F2—malignant glioma	0.000234	0.00135	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—FN1—malignant glioma	0.000234	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000232	0.00134	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—IDH2—malignant glioma	0.000231	0.00133	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTT1—malignant glioma	0.000227	0.00131	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CG—malignant glioma	0.000224	0.00129	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EGF—malignant glioma	0.000222	0.00128	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PTPN11—malignant glioma	0.00022	0.00127	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	0.000218	0.00125	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000217	0.00125	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2B6—malignant glioma	0.000217	0.00125	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS1—malignant glioma	0.000212	0.00122	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000212	0.00122	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.00021	0.00121	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT2—malignant glioma	0.000205	0.00118	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTT1—malignant glioma	0.000205	0.00118	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	0.000203	0.00117	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—IDH1—malignant glioma	0.000199	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCHE—malignant glioma	0.000198	0.00114	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CD—malignant glioma	0.000197	0.00114	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC5A5—malignant glioma	0.000195	0.00112	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SPHK1—malignant glioma	0.000192	0.00111	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS1—malignant glioma	0.000192	0.0011	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000191	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CYP2C18—malignant glioma	0.000188	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000185	0.00106	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000183	0.00105	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.00018	0.00103	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCHE—malignant glioma	0.000178	0.00103	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	0.000178	0.00102	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—RAF1—malignant glioma	0.000176	0.00101	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC5A5—malignant glioma	0.000176	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CB—malignant glioma	0.000172	0.00099	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000166	0.000959	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—malignant glioma	0.000166	0.000957	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000165	0.00095	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000162	0.000934	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	0.000162	0.000932	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000159	0.000918	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IL2—malignant glioma	0.000158	0.000909	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GSTP1—malignant glioma	0.000157	0.000905	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	0.000156	0.000899	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAT—malignant glioma	0.000153	0.000881	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000152	0.000878	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTT1—malignant glioma	0.000152	0.000877	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NCOR1—malignant glioma	0.000144	0.000832	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000144	0.000829	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS1—malignant glioma	0.000143	0.000822	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	0.000142	0.000819	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GSTP1—malignant glioma	0.000142	0.000817	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAT—malignant glioma	0.000138	0.000795	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—malignant glioma	0.000134	0.000773	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCHE—malignant glioma	0.000133	0.000764	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC5A5—malignant glioma	0.000131	0.000755	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NCOR1—malignant glioma	0.00013	0.00075	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000129	0.00074	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	0.000124	0.000714	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	0.000123	0.000707	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000121	0.000695	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CAV1—malignant glioma	0.000118	0.000678	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—malignant glioma	0.000114	0.000657	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000112	0.000648	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CG—malignant glioma	0.000107	0.000618	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	0.000107	0.000617	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CAV1—malignant glioma	0.000106	0.000612	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GSTP1—malignant glioma	0.000106	0.000608	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—malignant glioma	0.000105	0.000604	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—malignant glioma	0.000104	0.000596	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAT—malignant glioma	0.000103	0.000592	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	0.000101	0.000584	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—malignant glioma	0.000101	0.000584	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NCOR1—malignant glioma	9.7e-05	0.000559	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CG—malignant glioma	9.68e-05	0.000557	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CD—malignant glioma	9.43e-05	0.000543	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—malignant glioma	9.34e-05	0.000538	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—malignant glioma	8.56e-05	0.000493	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CD—malignant glioma	8.51e-05	0.00049	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CB—malignant glioma	8.22e-05	0.000473	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—malignant glioma	8.14e-05	0.000469	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CAV1—malignant glioma	7.91e-05	0.000456	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	7.56e-05	0.000435	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CB—malignant glioma	7.42e-05	0.000427	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—malignant glioma	7.35e-05	0.000423	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CG—malignant glioma	7.21e-05	0.000415	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTEN—malignant glioma	7.1e-05	0.000409	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—malignant glioma	6.95e-05	0.0004	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTEN—malignant glioma	6.41e-05	0.000369	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CD—malignant glioma	6.33e-05	0.000365	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CB—malignant glioma	5.52e-05	0.000318	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—malignant glioma	5.47e-05	0.000315	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—malignant glioma	5.01e-05	0.000288	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTEN—malignant glioma	4.77e-05	0.000275	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—malignant glioma	4.52e-05	0.00026	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—malignant glioma	4.09e-05	0.000236	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—malignant glioma	3.69e-05	0.000213	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—malignant glioma	3.37e-05	0.000194	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—malignant glioma	2.75e-05	0.000158	CbGpPWpGaD
